Annie Brooks
YOU?
Author Swipe
View article: Consensus expert recommendations for management of dysphagia during hospital admission in Parkinson's disease
Consensus expert recommendations for management of dysphagia during hospital admission in Parkinson's disease Open
Dysphagia is a common and often underrecognized symptom in patients with Parkinson's disease (PD) that is frequently overlooked during hospitalization. Dysphagia may be present without overt clinical signs, complicating timely identificati…
Improving recognition and management of inpatient delirium in Parkinson’s disease: evidence review and implications for clinical care Open
Delirium is an acute disturbance of attention, arousal, and cognition that fluctuates in severity and is a common yet under recognized complication in hospitalized patients with Parkinson’s disease. In Parkinson’s disease, symptoms such as…
Editorial: Hospitalization and Parkinson's disease: safety, quality and outcomes Open
EDITORIAL article Front. Aging Neurosci., 04 April 2024Sec. Parkinson's Disease and Aging-related Movement Disorders Volume 16 - 2024 | https://doi.org/10.3389/fnagi.2024.1398947
Standardizing default electronic health record tools to improve safety for hospitalized patients with Parkinson’s disease Open
Electronic Health Record (EHR) systems are often configured to address challenges and improve patient safety for persons with Parkinson’s disease (PWP). For example, EHR systems can help identify Parkinson’s disease (PD) patients across th…
Dysphagia and aspiration during a Parkinson's hospitalization: a care partner's perspective and recommendations for improving standards of care Open
People with Parkinson's disease have a significantly increased incidence and risk of aspiration pneumonia when compared to those without. Aspiration pneumonia associated with dysphagia (swallowing issues), which is the leading cause of dea…
A100 ORAL VANCOMYCIN THERAPY FOR CLOSTRIDIOIDES DIFFICILE INFECTION AND RISK OF INFECTION WITH GRAM-NEGATIVE ORGANISMS Open
Background Vancomycin is the recommended first-line therapy for mild to severe Clostridioides difficile infection (CDI). However, oral vancomycin is associated with disruption of the indigenous microbiota, predisposing patients to overgrow…
Oral Antimicrobial Agents for Urinary Tract Infections Due to Enterobacteriales Species Open
Background Urinary tract infections (UTIs) due to Enterobacteriales continue to pose a challenge because of increasing resistance rate to antimicrobial agents. The aim of this study was to evaluate in vitro susceptibility of oral antimicro…
Daptomycin use in adult inpatients in a Canadian tertiary care setting Open
Background: Daptomycin is approved by Health Canada for the treatment of Staphylococcus aureus bacteremia and complicated skin and soft tissue infections caused by gram-positive organisms, but is often used for other indications. We aimed …
View article: ICE volume 40 issue 8 Cover and Front matter
ICE volume 40 issue 8 Cover and Front matter Open
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Challenges of Antibiotic Stewardship on the Internal Medicine Ward Open
BACKGROUND: Audit and feedback programs are considered to be one of the most effective antimicrobial stewardship (ASP) strategies to improve antibiotic prescribing; however, resource requirements are a limiting factor. METHODS: In a contro…
Postexposure management of infectious diseases Open
Anyone exposed to an infectious disease--whether a healthcare provider, patient, or contact of a patient--should be evaluated promptly and the source of the infection identified. A systematic response entails postexposure prophylactic ther…
Does Extending Clostridium Difficile Treatment In Patients Who Are Receiving Concomitant Antibiotics Reduce The Rate Of Relapse Open
Purpose: Exposure to concomitant antibiotics during treatment for Clostridium difficile infection (CDI) is a major risk factor for relapse. This study compared the CDI relapse rates among patients who underwent CDI treatment while receivin…